INTRODUCTION AND OBJECTIVES:
Since the prostatespecific membrane antigen (PSMA) is highly expressed in the cell surface of the solid tumor microvasculature including renal cell carcinoma (RCC), our purpose was to clarify the clinical value of 68 Ga-PSMA PET/CT imaging in the diagnosis for RCC.
METHODS: All together 118 patients with RCC were involved in the study.
68
Ga-PSMA PET/CT was performed to detect both primary renal lesions or metastasis. Additionally, 68 Ga-PSMA PET/CT was performed every 3 month on 12 patients with metastasis undergoing target therapy to evaluate the treatment effect of target therapy. SUV max was calculated for all the PET-positive interested lesions.
RESULTS: After analysis for primary lesions, clear cell RCC (ccRCC) presented higher PSMA uptake than other pathologic type (papillary, chromophobe, et al) (SUV max : 17.30AE5.15 vs 5.72AE3.02, P<0.001, Fig.1A ). No differences were found among the groups of different WHO/ISUP Grade. Ga-PSMA PET/CT presented intense uptake on primary lesions (A, bilateral kidney cancer), lymph node (A) and bone (B) metastasis. Fig.2 The value of SUVmax reduced obviously presented the treatment effect of target therapy on lymph node metastasis (A) and primary kidney lesions (B).
CONCLUSIONS:
Ga-PSMA PET/CT presented great diagnostic value for ccRCC diagnosis.
68 Ga-PSMA PET/CT also presented the value of evaluate the therapeutic effect of first-line target therapy for advanced ccRCC.
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MP80-13 ANATOMICAL ACCURACY OF 3D PRINTED PATIENT-SPECIFIC KIDNEY MODELS USED FOR ROBOT-ASSISTED-PARTIAL NEPHRECTOMY PRE-OPERATIVE PLANNING (UROCCR STUDY N 39: 3D-PRINT)
INTRODUCTION AND OBJECTIVES: 3D printing is being used for surgical assistance during Robot-assisted Partial Nephrectomy (RAPN). We have also been using patient-specific 3D printed kidney models for patient education as well as a radiology education tool for medical students. The objective of this study was to assess objectively the anatomical accuracy of our 3D printed models used for RAPN and assess the quality of our workflow protocol behind the making of a 3D printed kidney model, from segmentation to postprocessing of the fabricated model. METHODS: We prospectively included patients who underwent 3D printing-assisted RAPN and anonymized computed tomography (CT). Patient consent for prospective collection of clinical data including imaging data inside UroCCR database was obtained (NCT03293563eCNIL DR 2013-206) . The preoperative CT was segmented with Synapse 3DÒ (FujifilmÒ). 3D files were processed before printing on the StratasysÒ-J750 3D printer, with vascular, urinary, parenchymal and tumor elements. The 3D printed model was then scanned. Six quantitative judgement criteria (major axis of the kidney and tumor, volume of the tumor, 3 measurements between arterial branches were used to blindly compare the initial patient CT and the 3D printed model CT ( fig.1 ). The correlation of the arterial distribution between the scanner and the 3D model was also evaluated on a Likert scale.
RESULTS: The first 16 patients of our 3D printing RAPN series were included between December 2017 and March 2018. The median tumor size was 5.1 cm. Between the initial CT scan and the 3D kidney, the major renal axis varied on average by 2.3% (AE1.8), the major tumor axis varied by 4.1%(AE4.2), mean tumor volume variation was 17.9% (AE10.4). Arterial inter-branch measurements, with 3 measurements performed on each kidney, ranged from 2.2%(AE1.5). The Likert scale e1166 THE JOURNAL OF UROLOGY Ò Vol. 201, No. 4S, Supplement, Monday, May 6, 2019 Copyright © 2019 American Urological Association Education and Research, Inc. Unauthorized reproduction of this article is prohibited.
